Clin2
NCT05729932Possibly a fitRecruiting

Cannabis and opioid use disorder study

Opioid Use Disorder

Part of Mental health clinical trials.

This Phase 1 trial studies cannabis in people with opioid use disorder. The goal is to better understand how it may affect opioid use disorder, while monitoring safety.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
15 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You currently have opioid use disorder
  • You must not have a current medical condition that needs ongoing medical treatment
  • Be prepared for medical checkups to confirm safety and study suitability
  • You may need medication and health review to make sure your conditions don’t require active treatment

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07668635Not yet recruiting· Phase 1
Cannabis effects on opioid use in withdrawal

This study tests whether cannabis can help people with opioid withdrawal and reduce opioid use. You will stay in a research center and receive cannabis in a controlled setting while researchers monitor your symptoms.

Lexington, Kentucky
NCT05985850Recruiting· Phase 2
Can cannabis help with opioid addiction treatment?

This trial tests if adding a specific cannabis product to standard methadone treatment helps people with opioid use disorder. It's for adults over 25 who recently started methadone and have used cannabis before.

Vancouver, British Columbia
NCT07148206Not yet recruiting· Phase 3
Cannabis medicines for opioid withdrawal with buprenorphine start

This trial tests whether two cannabis-based medicines, dronabinol and Epidiolex, can help ease withdrawal symptoms or cravings in people who have just started buprenorphine for opioid use disorder. It may be a good fit if you are early in treatment and still have symptoms or slip-ups.

The Bronx, New York
NCT06544291Recruiting· Phase 2
THC and CBD for pain and opioid use disorder

This study tests whether a combination of THC and CBD can help people who have both opioid use disorder and chronic low back pain. You would need to be on a stable dose of methadone and have used cannabis at least once in your life.

New Haven, Connecticut
NCT06796062Recruiting· Phase 2
Psilocybin for opioid use disorder

This study tests whether psilocybin can help people who want to stop using opioids and are already in treatment. Eligible participants receive a single dose of psilocybin in a supervised setting and are followed to see if it reduces opioid use.

Albuquerque, New Mexico
NCT04587791Recruiting· Early Phase 1
Cannabidiol (CBD) for opioid use disorder and chronic pain

This early study tests whether CBD can reduce symptoms of chronic pain in people receiving opioid maintenance treatment for opioid use disorder. It also looks at safety and whether CBD can be added without causing major problems.

West Haven, Connecticut

Hear when a new Opioid Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.